Ishikawa, Masatsune
Yamada, Shigeki
Miyajima, Masakazu
Kazui, Hiroaki
Mori, Etsuro
Article History
Received: 26 February 2021
Accepted: 19 May 2021
First Online: 3 June 2021
Competing interests
: MI received grants from the Health and Labor Sciences Research Grants for the Research on Intractable Diseases, Ministry of Health, Labor and Welfare Japan (2017-Nanci-037). SY received research funding from FUJIFILM Corporation and G-7 Scholarship Foundation. MM had no conflicts to declare. HK received honoraria from Eisai, Sumitomo Dainippon Pharma, Daiichi-Sankyo, Novartis, Janssen, Takeda, Otsuka, MSD, UCB, Eli Lilly, Towa, Integra Japan, and Nihon Medi-Physics. EM has received grant support from MHWL and Eisai; affiliation with an endowed chair from Sosei Heptares and Mentis Cura; personal compensation as a consultant/scientific advisory board member for Sosei Heptares and Mentis Cura; and honoraria from Eisai, Sumitomo Dainippon Pharma, Integra Japan, and Nihon Medi-Physics.